ERBB2 and breast neoplasm: Here, we used PET imaging to assess NK cell migration to human epidermal growth factor receptor 2 (HER2)–positive HCC1954 breast tumors, examining the influence of HER2-targeted trastuzumab antibody treatment on NK cell tumor accumulation.